Data / Form D filings / BioCurie, Inc.
BioCurie, Inc.: Form D filing
BioCurie, Inc., a biotechnology company in Wilmington, DE, filed a Form D with the SEC in 2025. The latest, on June 12, 2025, reports $500,000 sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 112 SOUTH FRENCH STREET, Wilmington, DE, 19801
- Phone
- (267) 449-1028
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2072544
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | New notice | $3,000,000 | $500,000 | $2,500,000 | 1 | Jun 3, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard D Braatz | Director | |
| Shen D Li | Director | |
| Jessica D Federer | Director | |
| Rosemary D Mazanet | Director | |
| Irene Romble | Executive Officer, Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Jun 9, 2025 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioCurie, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.